Drugs News and Research

RSS

Apotex passes Bill C-393 to fix Canada's Access to Medicines Regime

Apotex Inc, Canada's largest pharmaceutical company, today underscored the need for Members of Parliament to fix Canada's Access to Medicines Regime by passing Bill C-393 when it comes up for final vote tomorrow, March 9, 2011.

9 Mar 2011

'Cross-talk' between two major biological pathways may hold a clue for chronic pain treatment

Researchers at the University of California, Davis have discovered a "cross-talk" between two major biological pathways that involve pain-research that may pave the way to new approaches to understanding and controlling chronic pain.

9 Mar 2011

Multiple target therapy may treat HER2-positive breast cancers

Combining targeted therapies might be required for maximum anti-tumor activity when treating HER2-positive breast cancers, according to two new studies by Vanderbilt-Ingram Cancer Center investigators.

9 Mar 2011

Parkinson's disease medication turns on critical gene, protects brain cells

In a major breakthrough in the battle against Parkinson's disease, researchers at the University of Colorado School of Medicine have discovered a drug that stops the progression of the degenerative illness in mice and is now being tested in humans.

9 Mar 2011

USPTO grants new patent to Intellect's Alzheimer's vaccine

Intellect Neurosciences, Inc., a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced today that it has received a new patent from the United States Patent and Trademark Office in relation to the Company's RECALL-VAXTM technology platform.

9 Mar 2011

NHMRC awards $38.4M for cancer and blood cell research

Institute research into how cancer develops and blood cell production and function will today be awarded $38.4 million under the National Health and Medical Research Council's (NHMRC) program grants scheme.

9 Mar 2011

Patients with epilepsy-linked memory loss worry more than their physicians

Patients with epilepsy worry more than their physicians do about the patients' potential memory loss accompanying their seizure disorder, according to a recent study.

9 Mar 2011

Chemist discover new strategy to process certain drugs

A prolific University of Missouri chemist has discovered a quicker and easier method for pharmaceutical companies to make certain drugs.

9 Mar 2011

Chemotherapy drugs also kill malaria parasite

A group of researchers from EPFL's Global Health Institute (GHI) and Inserm (Institut National de la Sant- et de la Recherche M-dicale, the French government agency for biomedical research) has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria. The discovery could quickly open up a whole new strategy for combating this deadly disease.

9 Mar 2011

Smart technology for healthy longevity

A national policy is required for the research, demonstration, commercialisation and wide-scale deployment of smart technology for ageing-in-place to ensure: a healthy, safe, secure and fulfilling future for the increasing aged population in Australia by enabling them to remain at home longer, by easing the strain on the national healthcare system and providing cost effective solutions to meet the needs of the growing number of elderly Australians.

9 Mar 2011

Conflicts of interest overlooked in drug trial reviews: Study

A new study shows that researchers who review large sets of drug trials for medical journals – also known as meta analysis - often ignore financial conflicts that might affect the evidence and thereby conclusions.

8 Mar 2011

Single-wall carbon nanotubes targeted and killed cancer cells without harming the healthy cells

SouthWest NanoTechnologies’ (SWeNT) Single-Wall Carbon Nanotubes (SWCNT) exhibit promising potential for use in biomedical treatments such as cancer photo thermal therapies, new research reveals.

8 Mar 2011

$100 million in grants for medical research announced

More than $100 million in grants was announced this Tuesday for an ambitious research project that will try to find what makes cancer so hard to beat. This project received $21.3 million from the National Health and Medical Research Council grants.

8 Mar 2011

Recent rituximab trial with TNF inhibitors reports no new safety risks in patients with RA

A recent trial of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis found the safety profile to be consistent with other RA trials with TNF inhibitors.

8 Mar 2011

New insight into malaria

A group of researchers from EPFL's Global Health Institute and Inserm has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria.

8 Mar 2011

Compugen reports positive results from CGEN-25068 in animal model to treat certain disease conditions

Compugen Ltd. announced today positive animal model results for CGEN-25068, a novel peptide predicted and selected in silico to block a specific protein-protein interaction known to play an important role in various immune-related disease conditions.

8 Mar 2011

Anacor and iOWH establish research agreement to identify new drugs for shigellosis

Anacor Pharmaceuticals (NASDAQ:ANAC) and the Institute for OneWorld Health (iOWH) today announced the establishment of a joint research agreement to discover antibacterial compounds for treating shigellosis.

8 Mar 2011

Discovery of potent class of anti-cancer compounds by Scripps Research and MIT scientists

Working as part of a public program to screen compounds to find potential medicines and other biologically useful molecules, scientists from The Scripps Research Institute and Massachusetts Institute of Technology (MIT) have discovered an extremely potent class of potential anti-cancer and anti-neurodegenerative disorder compounds.

8 Mar 2011

URMC research confirms possible use of mifepristone for painful fibroids

Research continues to show that the controversial abortion drug mifepristone might have another use, as a therapeutic option besides hysterectomy for women who suffer from severe symptoms associated with uterine fibroids.

8 Mar 2011

Also in global health news: EU-India talks; China's health system funding; water in Ethiopia; nonprofit offering health services abroad to sell off assets; polio in India

BMJ News Examines Ongoing EU-India Trade Talks' Impact On Access To Affordable Medicines

8 Mar 2011

Drugs News and Research

Apotex passes Bill C-393 to fix Canada's Access to Medicines Regime

'Cross-talk' between two major biological pathways may hold a clue for chronic pain treatment

Multiple target therapy may treat HER2-positive breast cancers

Parkinson's disease medication turns on critical gene, protects brain cells

USPTO grants new patent to Intellect's Alzheimer's vaccine

NHMRC awards $38.4M for cancer and blood cell research

Patients with epilepsy-linked memory loss worry more than their physicians

Chemist discover new strategy to process certain drugs

Chemotherapy drugs also kill malaria parasite

Smart technology for healthy longevity

Conflicts of interest overlooked in drug trial reviews: Study

Single-wall carbon nanotubes targeted and killed cancer cells without harming the healthy cells

$100 million in grants for medical research announced

Recent rituximab trial with TNF inhibitors reports no new safety risks in patients with RA

New insight into malaria

Compugen reports positive results from CGEN-25068 in animal model to treat certain disease conditions

Anacor and iOWH establish research agreement to identify new drugs for shigellosis

Discovery of potent class of anti-cancer compounds by Scripps Research and MIT scientists

URMC research confirms possible use of mifepristone for painful fibroids

Also in global health news: EU-India talks; China's health system funding; water in Ethiopia; nonprofit offering health services abroad to sell off assets; polio in India

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News